Nanotechnology Now |
Home > Press > Needle-free vaccine technology a step closer to clinical trials
 |
| Professor Kendall with the Nanopatch |
Abstract:
Researchers at The University of Queensland believe they are a step closer to ridding the world of vaccinations with needles and syringes.
Needle-free vaccine technology a step closer to clinical trials
Brisbane | Posted on October 26th, 2010Professor Mark Kendall's team from the Australian Institute for Bioengineering and Nanotechnology (AIBN) has won a major award for their work on the needle-free vaccination delivery device Nanopatch.
As a consequence of winning the 2010 Translational Research Excellence Commercialisation Award, Professor Kendall will meet senior executives from global pharmaceutical company Merck Sharp and Dohme in the US.
The company will also pay up to $10,000 for Professor Kendall to attend the Bio 2011 convention in Washington DC.
Professor Kendall said winning the award was a "great shot in the arm" for his research team, providing both a pat on the back and a chance to move the technology forward.
"This is important, as it is a step towards partnering our Nanopatch with one of the world's leading vaccine companies," he said.
"Our ambition is for Nanopatch to be taken from the current stage of animal model success through the clinical trials, and on to the market as a next-generation vaccine delivery device, potentially displacing the needle and syringe.
"This progression requires commercialisation and partnership with the right players. This award is an important step along this pathway."
Nanopatch has been shown in trials to provide a protective immunisation in mice, with less than a hundredth of the dosage used compared to needle and syringe.
A part of the appeal of the Nanopatch is that it is painless, needle-free and is a potential solution for those with needle phobia.
Because the vaccine is formulated in dry form, it is also thermostable, removing the need for refrigeration.
Nanopatch is smaller than a postage stamp and is dissolvable, eliminating the possibility of needle-stick injury.
"When compared to needle and syringe immunisations - with all the associated costs - the Nanopatch is cheap to produce," Professor Kendall said.
"It is easy to imagine a situation in which a government might provide vaccinations for a pandemic such as swine flu to be collected from a chemist or sent in the mail."
Professor Kendall said the work had been in progress for five years and his team hoped to start clinical trials soon.
His research team has also been listed among the finalists in the Australian Museum Eureka Prizes and the UQ Business School's national Enterprize Business Plan Competition.
####
For more information, please click here
Contacts:
Professor Mark Kendall
3346 4203, 0431 162 391
Erik de Wit
07 3346 3962
Copyright © University of Queensland
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Products
Industrial Nanotech Launches Nansulate(R) Vinyl Fresh: Clear Liquid Thermal Insulation and UV Protection Coating Rejuvenates Vinyl Siding on Homes April 18th, 2013
MouthWatchers Nano-Silver Tooth Brush Released for Sale April 12th, 2013
Lurederra nanotechnology offers hydrofugant products for all types of substrate March 21st, 2013
Possible Futures
UC Santa Barbara History Professor's Book Elucidates, Celebrates ‘Visioneers' May 14th, 2013
Conceptual Nanomedical Lipofuscin Removal Strategy April 29th, 2013
The Global Desalination Market 2013-2023 April 24th, 2013
Academic/Education
The University of Wyoming uses Nanoparticle Tracking Analysis to characterize nanoparticles in natural environments May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013
Nanomedicine
Nanotechnology could help fight diabetes: Injectable nanogel can monitor blood-sugar levels and secrete insulin when needed May 16th, 2013
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Using clay to grow bone: Researchers use synthetic silicate to stimulate stem cells into bone cells May 15th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Grants/Awards/Scholarships/Gifts/Contests/Honors/Records
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Add boron for better batteries: Rice University theorists say graphene-boron mix shows promise for lithium-ion batteries May 17th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013
Nanobiotechnology
Advancements and developments of solid-state nanopores sensors May 16th, 2013
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||
abbigliamento uomo
Computer Accessories
| © Copyright 1999-2013 7th Wave, Inc. All Rights Reserved | PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE |